LivaNova PLC (LIVN) insider trading

By person

17 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Alex Shvartsburg

Chief Financial Officer

—

44,647

$3.48M

+138.4%

William A Kozy

Director

—

37,566

$2.93M

+36.8%

Stephanie Bolton

President, Global Epilepsy

—

22,189

$1.73M

+132.1%

Seng Stacy Enxing

Director

—

15,307

$1.19M

+75.0%

Vladimir Makatsaria

Chief Executive Officer

—

14,167

$1.11M

—

Todd C Schermerhorn

Director

—

12,619

$984.40K

+108.3%

Sharon O'Kane

Director

—

11,304

$881.82K

+19.1%

Franco Poletti

President, Cardiopulmonary

—

10,755

$838.99K

+61.3%

Peter M Wilver

Director

—

10,294

$803.03K

+175.8%

James Christopher Barry

Director

—

7,918

$617.68K

—

Brooke Story

Director

—

7,488

$584.13K

+115.4%

Michael Damon Hutchinson

SVP, CLO and Company Secretary

—

6,798

$530.31K

+197.4%

Ahmet Tezel

Chief Innovation Officer

—

6,090

$475.08K

—

Susan M Podlogar

Director

—

5,642

$440.13K

—

Natalia Kozmina

Chief Human Resources Officer

—

5,015

$391.22K

—

Francesco Bianchi

Director

—

4,434

$345.89K

−49.5%

Donald Zurbay

Director

—

2,252

$175.68K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

LivaNova PLC

What the insiders did No buying or selling

By person